FRANK BRESCIA

1.9k total citations
48 papers, 914 citations indexed

About

FRANK BRESCIA is a scholar working on Oncology, Public Health, Environmental and Occupational Health and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, FRANK BRESCIA has authored 48 papers receiving a total of 914 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Oncology, 15 papers in Public Health, Environmental and Occupational Health and 9 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in FRANK BRESCIA's work include Palliative Care and End-of-Life Issues (14 papers), Pain Management and Opioid Use (8 papers) and Ethics in medical practice (4 papers). FRANK BRESCIA is often cited by papers focused on Palliative Care and End-of-Life Issues (14 papers), Pain Management and Opioid Use (8 papers) and Ethics in medical practice (4 papers). FRANK BRESCIA collaborates with scholars based in United States and Spain. FRANK BRESCIA's co-authors include Russell K. Portenoy, Maurice E. Shils, Alan D. Turnbull, Ravinder Mamtani, Dean Schuyler, David J. Cole, Megan K. Baker, Robert B. Golbey, Gordon B. Magill and Robert I. Misbin and has published in prestigious journals such as New England Journal of Medicine, Journal of the American Chemical Society and Journal of Clinical Oncology.

In The Last Decade

FRANK BRESCIA

45 papers receiving 844 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
FRANK BRESCIA United States 16 275 245 241 230 153 48 914
Paul Daeninck Canada 17 259 0.9× 125 0.5× 124 0.5× 170 0.7× 86 0.6× 34 785
Steven H. Krasnow United States 17 124 0.5× 249 1.0× 85 0.4× 147 0.6× 228 1.5× 42 1.2k
Alessio Gamba Italy 9 197 0.7× 292 1.2× 141 0.6× 162 0.7× 110 0.7× 21 668
Selina Chow United States 15 149 0.5× 149 0.6× 93 0.4× 156 0.7× 59 0.4× 54 700
Debra Wujcik United States 14 297 1.1× 503 2.1× 122 0.5× 202 0.9× 71 0.5× 56 975
Julia Ridley Canada 11 370 1.3× 219 0.9× 40 0.2× 147 0.6× 57 0.4× 16 699
Debika Burman Canada 13 622 2.3× 529 2.2× 40 0.2× 338 1.5× 91 0.6× 15 1.0k
Martin Tattersall Australia 19 645 2.3× 397 1.6× 28 0.1× 290 1.3× 207 1.4× 43 1.5k
Connie Henke Yarbro United States 11 123 0.4× 286 1.2× 35 0.1× 147 0.6× 73 0.5× 24 639
Maddalena Cross Australia 17 266 1.0× 32 0.1× 48 0.2× 130 0.6× 246 1.6× 40 963

Countries citing papers authored by FRANK BRESCIA

Since Specialization
Citations

This map shows the geographic impact of FRANK BRESCIA's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by FRANK BRESCIA with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites FRANK BRESCIA more than expected).

Fields of papers citing papers by FRANK BRESCIA

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by FRANK BRESCIA. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by FRANK BRESCIA. The network helps show where FRANK BRESCIA may publish in the future.

Co-authorship network of co-authors of FRANK BRESCIA

This figure shows the co-authorship network connecting the top 25 collaborators of FRANK BRESCIA. A scholar is included among the top collaborators of FRANK BRESCIA based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with FRANK BRESCIA. FRANK BRESCIA is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
BRESCIA, FRANK, et al.. (2025). Rechallenge of an alternative CDK 4/6 inhibitor after hepatotoxicity in the treatment of hormone-positive metastatic breast cancer. Journal of Oncology Pharmacy Practice. 31(7). 1174–1178. 1 indexed citations
2.
Ramanathan, Ramesh K., Joel Picus, H. Raftopoulos, et al.. (2007). A phase II study of milataxel: a novel taxane analogue in previously treated patients with advanced colorectal cancer. Cancer Chemotherapy and Pharmacology. 61(3). 453–458. 24 indexed citations
3.
Brown, Ronald T., Bernard F. Fuemmeler, David G. Anderson, et al.. (2006). Adjustment of Children and Their Mothers with Breast Cancer. Journal of Pediatric Psychology. 32(3). 297–308. 34 indexed citations
4.
BRESCIA, FRANK. (2004). Palliative Care in Pancreatic Cancer. Cancer Control. 11(1). 39–45. 17 indexed citations
5.
BRESCIA, FRANK. (2004). Palliative Care in Pancreatic Cancer. Cancer Control. 11(2). 39–45. 20 indexed citations
6.
BRESCIA, FRANK. (2004). Philosophical Oncology: On Being Needed—Thoughts of a Deathwatcher. Cancer Investigation. 22(3). 466–470. 1 indexed citations
7.
Baker, Megan K., Kaidi Mikhitarian, Walid Osta, et al.. (2003). Molecular detection of breast cancer cells in the peripheral blood of advanced-stage breast cancer patients using multimarker real-time reverse transcription-polymerase chain reaction and a novel porous barrier density gradient centrifugation technology.. PubMed. 9(13). 4865–71. 80 indexed citations
8.
BRESCIA, FRANK. (2003). Philosophical Oncology: Calling on the Principle of Double Effect. Journal of the National Comprehensive Cancer Network. 1(3). 429–434. 4 indexed citations
9.
Newton, Danforth A., et al.. (2002). Semi-Allogeneic Vaccines for Patients With Cancer and AIDS. Journal of Immunotherapy. 25(4). 334–341. 5 indexed citations
11.
BRESCIA, FRANK. (2001). Lung cancer — a philosophical, ethical, and personal perspective. Critical Reviews in Oncology/Hematology. 40(2). 139–148. 15 indexed citations
12.
Portenoy, Russell K., Nessa Coyle, Kathryn M. Kash, et al.. (1997). Determinants of the Wiffingness to Endorse Assisted Suicide. Psychosomatics. 38(3). 277–287. 74 indexed citations
13.
BRESCIA, FRANK, et al.. (1992). Pain, opioid use, and survival in hospitalized patients with advanced cancer.. Journal of Clinical Oncology. 10(1). 149–155. 107 indexed citations
14.
BRESCIA, FRANK. (1991). Killing the known dying: Notes of a death watcher. Journal of Pain and Symptom Management. 6(5). 337–339. 9 indexed citations
15.
BRESCIA, FRANK. (1990). The goals and challenges of palliative care: Thoughts of a deathwatcher. Journal of Pain and Symptom Management. 5(6). 382–384. 2 indexed citations
16.
BRESCIA, FRANK. (1990). The responsible physician: Standards of excellence and the critically Ill patient. Journal of Pain and Symptom Management. 5(5). 339–340. 1 indexed citations
17.
BRESCIA, FRANK, et al.. (1990). Hospitalized advanced cancer patients: A profile. Journal of Pain and Symptom Management. 5(4). 221–227. 84 indexed citations
18.
BRESCIA, FRANK, et al.. (1988). The advanced cancer patient--a clinical profile.. PubMed. 278. 137–46. 1 indexed citations
19.
BRESCIA, FRANK. (1987). An overview of pain and symptom management in advanced cancer. Journal of Pain and Symptom Management. 2(2). S7–S11. 7 indexed citations
20.
BRESCIA, FRANK. (1959). Letters to the editor. Journal of Chemical Education. 36(8). 416–416.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026